These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9662308)

  • 21. Breast biopsy with needle localization: influence of age and mammographic feature on the rate of malignancy in 350 nonpalpable breast lesions.
    Hasselgren O; Hummel RP; Fieler MA
    Surgery; 1991 Oct; 110(4):623-7; discussion 627-8. PubMed ID: 1925952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in the management of breast cancer. 2. Occult breast lesions: when and how to perform a biopsy for mammographic abnormalities.
    Robidoux A
    Can J Surg; 1992 Aug; 35(4):366-70. PubMed ID: 1498736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic core breast biopsy. An alternative.
    Brendlinger DL; Robinson R; Sylvest V; Burton S
    Va Med Q; 1994; 121(3):179-84. PubMed ID: 8061069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotaxic needle localization and biopsy of occult breast lesions: first year's experience.
    Elliott RL; Haynes AE; Bolin JA; Boagni EM; Head JF
    Am Surg; 1992 Feb; 58(2):126-31. PubMed ID: 1550304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities.
    Rodhouse C; Soliman I; Cruse M; Kastrenakes J; Augustine CJ; Ludy A; Reintgen E; Hoadley A; Desai D; Nguyen M; Reintgen DS
    Clin Breast Cancer; 2017 Feb; 17(1):18-22. PubMed ID: 27864044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective evaluation of surgically treated cases of non-palpable breast tumor].
    Dubecz S; Petri K; Szabó E; Riedl E; Péley G; Rahóty P; Bak M; Köves I
    Magy Seb; 2001 Aug; 54(4):203-7. PubMed ID: 11550484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
    Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
    Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of stereotaxic large-core needle biopsy and surgical biopsy results in nonpalpable breast lesions.
    Kopans DB
    Radiology; 1993 Dec; 189(3):665-6. PubMed ID: 8234687
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonpalpable breast lesions: stereotactic automated large-core biopsies.
    Parker SH; Lovin JD; Jobe WE; Burke BJ; Hopper KD; Yakes WF
    Radiology; 1991 Aug; 180(2):403-7. PubMed ID: 1648757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens.
    Liberman L; Evans WP; Dershaw DD; Hann LE; Deutch BM; Abramson AF; Rosen PP
    Radiology; 1994 Jan; 190(1):223-5. PubMed ID: 8259409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy.
    Winchester DJ; Bernstein JR; Jeske JM; Nicholson MH; Hahn EA; Goldschmidt RA; Watkin WG; Sener SF; Bilimoria MB; Barrera E; Winchester DP
    Arch Surg; 2003 Jun; 138(6):619-22; discussion 622-3. PubMed ID: 12799332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
    Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
    Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of double diagnosis of nonpalpable lesions of the breast.
    Dowlatshahi K; Jokich PM; Kluskens LF; Patel R; Economou SG
    Surg Gynecol Obstet; 1991 Feb; 172(2):121-4. PubMed ID: 1846452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant hamartoma of the breast treated by the mammaplasty approach.
    Hernanz F; Vega A; Palacios A; Fleitas MG
    ANZ J Surg; 2008 Mar; 78(3):216-7. PubMed ID: 18269499
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of Localization and Needle Placement Guided by Mammographic, Ultrasound and Fiberoptic Ductoscopy for Resection of Non-palpable Breast Lesions.
    Yuan Z; Qu X; Zhang ZT; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4523-4527. PubMed ID: 28739748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced breast cancer biopsy instrumentation: a critique.
    Ferzli GS; Hurwitz JB; Puza T; Van Vorst-Bilotti S
    J Am Coll Surg; 1997 Aug; 185(2):145-51. PubMed ID: 9249081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of surgery for non-palpable mammographic abnormalities.
    Aitken RJ; MacDonald HL; Kirkpatrick AE; Anderson TJ; Chetty U; Forrest AP
    Br J Surg; 1990 Jun; 77(6):673-6. PubMed ID: 2383738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy].
    Liu GY; Chen CM; Hu Z; Ling H; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1322-4. PubMed ID: 17217817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stereotactic and ultrasound guided fine-needle cytology in nonpalpable breast lesions].
    Vielh P; Klijanienko J
    Arch Anat Cytol Pathol; 1998; 46(4):237-40. PubMed ID: 9754384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.